GATAD2A and breast cancer: To further strengthen the functional role of CARM1-mediated GATAD2A methylation in breast cancer, EZM2302 significantly inhibited GATAD2A methylation and GATAD2A binding on the promoter regions of representative cell cycle genes in MDA-MB-231 cells (Supplementary Figure S7F and G).